Skip to main content

Table 2 Admission signs and symptoms of enrolled patients according to age groups. * 1 patient not assigned to any of the age classes, due to missing value

From: Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study

Symptom

< 2 years

(n = 92)

2–10 years

(n = 50)

> 10 years

(n = 24)

Total

(n = 167)*

General symptoms

Hystory of fever

78 (85.9%)

39 (78.0%)

19 (79.2%)

138 (82.6%)

Respiratory symptoms

Cough

37 (40.2%)

16 (32.0%)

10 (41.7%)

63 (37.7%)

Runny nose (rhinorrhoea)

31 (33.7%)

9 (18.0%)

4 (16.7%)

44 (26.3%)

Ear pain

1 (1.1%)

0 (0.0%)

0 (0%)

1 (0.6%)

Wheezing

4 (4.3%)

2 (4.0%)

3 (12.5%)

9 (3.6%)

Shortness of breath (dyspnea)

8 (8.7%)

7 (14.0%)

9 (37.5%)

24 (14.4%)

Muscoloskeletal symptoms

Muscle aches (myalgia)

0 (0.0%)

4 (8.0%)

4 (16.7%)

8 (4.9%)

Joint pain (arthralgia)

0 (0.0%)

3 (6.0%)

2 (8.3%)

5 (3.0%)

Fatigue / malaise

2 (2.2%)

6 (12.0%)

6 (25.0%)

14 (8.4%)

Neurological symptoms

Headache

0 (0%)

7 (14.0%)

5 (20.8%)

12 (7.1%)

Alteredconsciousness/confusion

2 (2.2%)

6 (12.0%)

2 (8.3%)

10 (6.0%)

Seizures

4 (4.3%)

13 (26.2%)

1 (4.2%)

18 (10.8%)

Gastrointestinal symptoms

Abdominal pain

2 (2.2%)

9 (18.0%)

6 (25.0%)

17 (10.2%)

Vomiting / nausea

20 (21.7%)

13 (26.0%)

8 (33.3%)

42 (25.1%)

Diarrhoea

15 (16.3%)

2 (4.0%)

5 (20.8%)

22 (13.2%)

Hypoalimentation

44 (47.8%)

18 (36.0%)

8 (33.3%)

70 (41.9%)

Skin mucosal symptoms

Conjunctivitis

4 (4.3%)

2 (4.0%)

0 (0.0%)

6 (3.6%)

Skin rash

3 (3.3%)

6 (12.0%)

1 (4.2%)

10 (6.0%)

Lymphadenopathy

0 (0%)

6 (12.0%)

1 (4.2%)

7 (4.2%)